Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic mice. [electronic resource] by
- Timakhov, Roman A
- Tan, Yinfei
- Rao, Mamta
- Liu, Zemin
- Altomare, Deborah A
- Pei, Jianming
- Wiest, David L
- Favorova, Olga O
- Knepper, Janice E
- Testa, Joseph R
Producer: 20091002
In:
Genes, chromosomes & cancer vol. 48
Availability: No items available.
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. [electronic resource] by
- Altomare, Deborah A
- You, Huihong
- Xiao, Guang-Hui
- Ramos-Nino, Maria E
- Skele, Kristine L
- De Rienzo, Assunta
- Jhanwar, Suresh C
- Mossman, Brooke T
- Kane, Agnes B
- Testa, Joseph R
Producer: 20051014
In:
Oncogene vol. 24
Availability: No items available.
|
|
34.
|
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. [electronic resource] by
- Altomare, Deborah A
- Menges, Craig W
- Xu, Jinfei
- Pei, Jianming
- Zhang, Lili
- Tadevosyan, Ara
- Neumann-Domer, Erin
- Liu, Zemin
- Carbone, Michele
- Chudoba, Ilse
- Klein-Szanto, Andres J
- Testa, Joseph R
Producer: 20110816
In:
PloS one vol. 6
Availability: No items available.
|
|
35.
|
A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice. [electronic resource] by
- Tan, Yinfei
- Timakhov, Roman A
- Rao, Mamta
- Altomare, Deborah A
- Xu, Jinfei
- Liu, Zemin
- Gao, Qingshen
- Jhanwar, Suresh C
- Di Cristofano, Antonio
- Wiest, David L
- Knepper, Janice E
- Testa, Joseph R
Producer: 20080408
In:
Cancer research vol. 68
Availability: No items available.
|
|
36.
|
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. [electronic resource] by
- Garland, Linda L
- Rankin, Cathryn
- Gandara, David R
- Rivkin, Saul E
- Scott, Katherine M
- Nagle, Raymond B
- Klein-Szanto, Andres J P
- Testa, Joseph R
- Altomare, Deborah A
- Borden, Ernest C
Producer: 20070712
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 25
Availability: No items available.
|
|
37.
|
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary. [electronic resource] by
- Mabuchi, Seiji
- Kawase, Chiaki
- Altomare, Deborah A
- Morishige, Kenichirou
- Sawada, Kenjiro
- Hayashi, Masami
- Tsujimoto, Masahiko
- Yamoto, Mareo
- Klein-Szanto, Andres J
- Schilder, Russell J
- Ohmichi, Masahide
- Testa, Joseph R
- Kimura, Tadashi
Producer: 20091211
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15
Availability: No items available.
|
|
38.
|
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary. [electronic resource] by
- Mabuchi, Seiji
- Kawase, Chiaki
- Altomare, Deborah A
- Morishige, Kenichirou
- Hayashi, Masami
- Sawada, Kenjiro
- Ito, Kimihiko
- Terai, Yoshito
- Nishio, Yukihiro
- Klein-Szanto, Andres J
- Burger, Robert A
- Ohmichi, Masahide
- Testa, Joseph R
- Kimura, Tadashi
Producer: 20101126
In:
Molecular cancer therapeutics vol. 9
Availability: No items available.
|
|
39.
|
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. [electronic resource] by
- Menges, Craig W
- Kadariya, Yuwaraj
- Altomare, Deborah
- Talarchek, Jacqueline
- Neumann-Domer, Erin
- Wu, Yue
- Xiao, Guang-Hui
- Shapiro, Irina M
- Kolev, Vihren N
- Pachter, Jonathan A
- Klein-Szanto, Andres J
- Testa, Joseph R
Producer: 20140422
In:
Cancer research vol. 74
Availability: No items available.
|